Delivery Order SPE2DB22D3009-SPE2DB23FAX48

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $89,099.58, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the...
This federal contract award, valued at $3,226.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product, to support U.S. government medical needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,661.59, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, which runs through December 2025. The IDC serves as the primary vehicle...
This federal contract award, valued at $13,865.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, and has a performance period ending on September 27, 2023. The contract was awarded as a delivery order without any set-aside designation, indicating it was competed on an open-market basis. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,269.71, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, valued at $92,410.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through February 28, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,263.10 firm fixed-price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance ending on January 11, 2024. The award is not associated with any set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
This federal contract award, valued at $33,539.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of Bridion 500 mg/5 ml vials, a specialty medication used for medical care. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $63,277.23, is a delivery order for the supply of BRIDION 500 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 30, 2021. This award is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,030.55, is for the delivery of 4563579837 - BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The award represents a delivery order against Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB23FAX48
    Delivery Order

This federal contract award, valued at $3,280.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product BRIDION 200 MG/2 ML VIAL 2ML.

The award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/12/25, 9:43 AM